In Brief: MEHL/Biophile vs. Palomar
This article was originally published in The Gray Sheet
Executive SummaryMEHL/Biophile vs. Palomar: Selvac Acquisition Corp. subsidiary of MEHL/Biophile International files patent infringement suit March 7 in the U.S. District Court of New Jersey against Palomar Medical Technologies. The suit alleges Palomar infringement of a patent licensed by MEHL/Biophile on a method of laser hair removal...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.